Page last updated: 2024-12-08

gamma-glutamyl-2-naphthylamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gamma-glutamyl-2-naphthylamide: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-(alpha-L-glutamyl)-2-naphthylamine : An L-glutamic acid derivative that is the amide obtained by formal condensation of the alpha-carboxy group of L-glutamic acid with the amino group of 2-naphthylamine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID164706
CHEBI ID90440
MeSH IDM0081574

Synonyms (23)

Synonym
glutamic acid beta-naphthylamide
635-86-9
n-2-naphthylglutamine
(4s)-4-amino-5-(naphthalen-2-ylamino)-5-oxopentanoic acid
n-2-naphthalenyl-l-glutamine
alpha-gluna
gamma-glutamyl-2-naphthylamide
l-gamma-glutamyl-2-naphthylamide
l-glutamic acid beta-naphthylamide
n-(alpha-l-glutamyl)-2-naphthylamine
l-glutamic acid 2-naphthylamide
CHEBI:90440
(4s)-4-amino-5-[(naphthalen-2-yl)amino]-5-oxopentanoic acid
n-naphthalen-2-yl-l-alpha-glutamine
mfcd00037740
h-glu-bna
Q27162545
DTXSID80979720
4-amino-5-hydroxy-5-[(naphthalen-2-yl)imino]pentanoic acid
(s)-4-amino-5-(naphthalen-2-ylamino)-5-oxopentanoic acid
(s)-4-amino-5-(naphthalen-2-ylamino)-5-oxopentanoicacid
BS-29118
l-glu-betana
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
chromogenic compoundColourless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into coloured compounds. They are used in biochemical assays and in diagnosis as indicators, particularly in the form of enzyme substrates.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
N-(2-naphthyl)carboxamideAny carboxamide resulting from the formal condensation of a carboxylic acid with 2-naphthylamine.
amino acid amideAn amide of an amino acid formed formally by conversion of the carboxy group to a carboxamido group.
L-glutamic acid derivativeA proteinogenic amino acid derivative resulting from reaction of L-glutamic acid at the amino group or either of the carboxy groups, or from the replacement of any hydrogen of L-glutamic acid by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.35 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]